Tag: 6

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

Family physician, experienced health care executive, and U.S. Navy Veteran will work to advance health equity and community well-being CAMARILLO, Calif., July 21, 2025 /PRNewswire/...

TORONTO, July 21, 2025 /PRNewswire/ - Spin Master Corp. ("Spin Master") (TSX: TOY), a leading global children's entertainment company, today announced a time change...

Solid low-cost production profile from year one via a phased mine plan:Phase 1: Low Initial capital cost of $155 million, builds average annual gold...

TORONTO, July 21, 2025 /CNW/ - Bank of Montreal (TSX: BMO) (NYSE: BMO or the "Bank") today announced the pricing of USD 1.0 billion...

Solid low-cost production profile from year one via a phased mine plan:Phase 1: Low Initial capital cost of $155 million, builds average annual gold...

LEXINGTON, Ky., July 21, 2025 /PRNewswire/ -- Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, today announced that it plans...

Revenues of $9.3 million, up 86% YoY; The first-half year revenues of $17.3 million, 89% of full year 2024.Adjusted EBITDA of $1.6 million, up...

SINGAPORE, July 21, 2025 /PRNewswire/ -- BTC Digital Ltd. (Nasdaq: BTCT) (the "Company") announced today that its previously announced extraordinary general meeting (the "Meeting"), originally...

Continued Strong Performance CHICAGO, July 21, 2025  /PRNewswire/ -- Equity LifeStyle Properties, Inc. (NYSE: ELS) (referred to herein as "we," "us," and "our") today announced...

DUBLIN, July 21, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to six (6) new employees to purchase 34,200 ordinary shares under Avadel’s 2021 Inducement Plan. The awards were granted as an inducement material to the employee’s acceptance of employment with Avadel in accordance with Nasdaq Listing Rule 5635(c)(4). The options have a ten-year term and vest over four years, with 25% vesting on the one-year anniversary of each new employee’s respective start date and 25% vesting on the second, third, and fourth anniversary thereafter. The options are subject to the terms and conditions of Avadel’s 2021 Inducement Plan approved by the Board of Directors in November 2021 and the terms and conditions of award agreements covering the grants.

VANCOUVER, BC, July 21, 2025 /PRNewswire/ - Kootenay Silver Inc. ("Kootenay" or the "Company") (TSXV: KTN) (OTCQX: KOOYF) is pleased to announce drill crews...